A Mendelian randomization study of the role of lipoprotein subfractions in coronary artery disease
Qingyuan ZhaoiD, Jingshu WangiD, Zhen MiaoiD, Nancy Ruonan ZhangiD, Sean HennessyiD, Dylan S. SmalliD, Daniel James RaderiD
Abstract
Recent genetic data can offer important insights into the roles of lipoprotein subfractions and particle sizes in preventing coronary artery disease (CAD), as previous observational studies have often reported conflicting results. In this study, we first used the LD score regression to estimate the genetic correlation of 77 subfraction traits with traditional lipid profile and identified 27 traits that may involve distinct genetic mechanisms. We then used Mendelian randomization (MR) to estimate the causal effect of these traits on the risk of CAD. In univariable MR, the concentration and content of medium high-density lipoprotein (HDL) particles showed a protective effect against coronary artery disease. The effect was not attenuated in multivariable MR that adjusted for traditional lipid profile. The multivariable MR analyses also found that small HDL particles and smaller mean HDL particle diameter may have a protective effect. We identified four genetic markers for HDL particle size and CAD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 54
- FWCI
- 4.66
- Field percentile
- top 4%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A robust and efficient method for Mendelian randomization with hundreds of genetic variants: unravelling mechanisms linking HDL-cholesterol and coronary heart disease
Stephen Burgess, Christopher N. Foley, … Joanna M. M. Howson·bioRxiv·Mar 4, 2019
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
María Gordillo‐Marañón, Magdalena Zwierzyna, … Chris Finan·Nature CommunicationsPeer-reviewed·Oct 21, 2021
- Distinguishing genetic correlation from causation across 52 diseases and complex traits
Luke Jen O’Connor, Alkes L. Price·Nature GeneticsPeer-reviewed·Oct 25, 2018
- Proteomic Insights into Lp(a) Cardiovascular Mechanisms: A Mendelian Randomization Study
Julia Tomasi, Huilei Xu, … JP Casas·medRxiv·Apr 22, 2026
- Evaluating the effects of alcohol and tobacco use on cardiovascular disease using multivariable Mendelian randomization
Daniel B. Rosoff, George Davey Smith, … Falk W. Lohoff·bioRxiv·Sep 6, 2019
- Metabolomic signatures of lipid-modifying therapies using drug target Mendelian randomization
Tom G. Richardson, Genevieve M Leyden, … Michael Vaclav Holmes·PLoS BiologyPeer-reviewed·Feb 25, 2022